Table 6.
Univariate survival analysis: progression rate in low- and high-risk groups of sCr, proteinuric, and histologic parameters in 23 patients treated with steroids and cyclophosphamidea
| Risk Factors | Progression | P |
|---|---|---|
| sCr < versus ≥1.74 (12 versus 11) | 0 versus 73% | <0.0001 |
| FEIgG/SG < versus ≥0.00034 (14 versus 9) | 0 versus 89% | <0.0001 |
| FEIgG/SG + sCr (15 versus 8)b | 0 versus 100% | <0.0001 |
| FEα1m/SG < versus ≥0.04 (12 versus 11) | 0 versus 73% | <0.0003 |
| TID score < versus ≥3 (8 versus 15) | 0 versus 53% | 0.0210 |
| GGS < versus ≥20% (12 versus 11) | 8 versus 64% | 0.0074 |
| uα2m/g uCr/SG < versus ≥0.11 (15 versus 8) | 7 versus 87% | 0.0004 |
| 24hP/SG < versus ≥0.034 (9 versus 14) | 0 versus 57% | 0.0120 |
| Cellular crescents < versus ≥17% (8 versus 15) | 25 versus 40% | 0.5960 |
a
Numbers in parentheses are the number of patients of the low- and high-risk groups, respectively.
b
Low-risk group: the two markers or only one below the cutoff; high-risk group: both markers above the cutoff.